Oluwatosin A Saibu, Sodiq O Hammed, Oladapo O Oladipo, Tope T Odunitan, Temitope M Ajayi, Aderonke J Adejuyigbe, Boluwatife T Apanisile, Oluwatoba E Oyeneyin, Adenrele T Oluwafemi, Tolulope Ayoola, Olamide T Olaoba, Abdullahi O Alausa, Damilola A Omoboyowa
Journal: Bioorganic & medicinal chemistry 2023;81():117211
PMID: 36809721
Protein-protein interactions (PPIs) are essential in normal biological processes, but they can become disrupted or imbalanced in cancer. Various technological advancements have led to an increase in the number of PPI inhibitors, which target hubs in cancer cell's protein networks. However, it remains difficult to develop PPI inhibitors with desired potency and specificity. Supramolecular chemistry has only lately become recognized as a promising method to modify protein activities. In this review, we highlight recent advances in the use of supramolecular modification approaches in cancer therapy. We make special note of efforts to apply supramolecular modifications, such as molecular tweezers, to targeting the nuclear export signal (NES), which can be used to attenuate signaling processes in carcinogenesis. Finally, we discuss the strengths and weaknesses of using supramolecular approaches to targeting PPIs.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Medical:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.